Home LiteratureArticle Details
PMID: 2006245 Published · ppublish English Clinical Trial Comparative Study Controlled Clinical Trial Journal Article

Models of memory dysfunction? A comparison of the effects of scopolamine and lorazepam on memory, psychomotor performance and mood.

Psychopharmacology ·Vol. 103 ·No. 1 ·1991-00-00 ·Pages 83-90

Curran HV, Schifano F, Lader M

Abstract

The effects on memory, psychomotor functions and mood of intramuscular scopolamine (0.3 mg, 0.6 mg) were compared with those of oral lorazepam (2 mg) and placebo. Thirty-six volunteers took part in a double-blind, independent groups design. Subjects completed a battery of tests 1 and 3 h after drug administration. Both doses of scopolamine produced levels of sedation comparable to that produced by lorazepam. The time course of effects of scopolamine and lorazepam differed but the pattern of psychomotor impairments and amnestic effects produced was very similar. In terms of mood, lorazepam had an anxiolytic effect whereas scopolamine increased ratings of anxiety. Levels of sedation, indexed by either subjective ratings or motor retardation (tapping speed), were related more to psychomotor performance than to performance on memory tasks. The results suggest that benzodiazepines and scopolamine have similar amnestic and sedative effects and as such may not offer distinct models of memory dysfunction.

MeSH Terms
Adult Affect/drug effects Anxiety/psychology Double-Blind Method Female Flicker Fusion/drug effects Humans Hypnotics and Sedatives Lorazepam/pharmacology Male Memory Disorders/drug therapy,psychology Middle Aged Models, Psychological Psychomotor Performance/drug effects Salivation/drug effects Scopolamine/pharmacology Vision, Ocular/drug effects
Chemicals
Hypnotics and Sedatives Scopolamine Lorazepam
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Curran H V
Department of Psychiatry, Institute of Psychiatry, London, UK.
Schifano F
Lader M
References (24)
24 references, click to expand
  1. Anticholinergic sensitivity in patients with dementia of the Alzheimer type and age-matched controls. A dose-response study.
    Arch Gen Psychiatry. 1987 May;44(5):418-26 PMID: 3579494
  2. Patterns of memory failure after scopolamine treatment: implications for cholinergic hypotheses of dementia.
    Behav Neural Biol. 1986 Mar;45(2):196-211 PMID: 2938571
  3. Mental rotation of three-dimensional objects.
    Science. 1971 Feb 19;171(3972):701-3 PMID: 5540314
  4. Modelling dementia: effects of scopolamine on memory and attention.
    Neuropsychologia. 1988;26(5):685-700 PMID: 3211287
  5. Human information-processing: some effects of methylphenidate, age, and scopolamine.
    Biol Psychiatry. 1984 May;19(5):649-62 PMID: 6733179
  6. Models of memory dysfunctions.
    Ann N Y Acad Sci. 1985;444:359-69 PMID: 2990294
  7. Differential amnesic properties of benzodiazepines: a dose-response comparison of two drugs with similar elimination half-lives.
    Psychopharmacology (Berl). 1987;92(3):358-64 PMID: 3114788
  8. Dissociative effects of scopolamine on working memory in healthy young volunteers.
    Psychopharmacology (Berl). 1988;96(4):487-92 PMID: 3149771
  9. The effects of scopolamine on working memory in healthy young volunteers.
    Psychopharmacology (Berl). 1988;96(2):145-52 PMID: 3148139
  10. Qualitative analysis of scopolamine-induced amnesia.
    Psychopharmacology (Berl). 1981;74(1):74-80 PMID: 6791209
  11. Amnesic sensitivity to proactive interference: its relationship to priming and the causes of amnesia.
    Neuropsychologia. 1987;25(1B):211-20 PMID: 3574659
  12. Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine.
    Psychopharmacology (Berl). 1989;98(4):487-94 PMID: 2570433
  13. The effects of scopolamine upon verbal memory: evidence for an attentional hypothesis.
    Acta Psychol (Amst). 1985 Mar;58(3):205-17 PMID: 3993408
  14. The effects of intravenous diazepam and hyoscine upon human memory.
    Q J Exp Psychol A. 1984 Feb;36(1):133-44 PMID: 6536036
  15. Psychomotor, physiological and cognitive effects of scopolamine and ephedrine in healthy man.
    Eur J Clin Pharmacol. 1983;24(5):603-9 PMID: 6873137
  16. Cholinergic function and intellectual decline in Alzheimer's disease.
    Neuroscience. 1986 Sep;19(1):1-28 PMID: 3537837
  17. The SHP test--an aid in the detection and measurement of depression.
    AMA Arch Gen Psychiatry. 1959 Jul;1:35-40 PMID: 14431290
  18. Cholinergic 'blockade' as a model for cholinergic depletion. A comparison of the memory deficits with those of Alzheimer-type dementia and the alcoholic Korsakoff syndrome.
    Brain. 1988 Oct;111 ( Pt 5):1079-110 PMID: 3179685
  19. Tranquillising memories: a review of the effects of benzodiazepines on human memory.
    Biol Psychol. 1986 Oct;23(2):179-213 PMID: 2878691
  20. The effects of intravenous diazepam and hyoscine upon recognition memory.
    Behav Brain Res. 1984 Dec;14(3):193-9 PMID: 6525242
  21. Effects of diazepam and scopolamine on storage, retrieval and organizational processes in memory.
    Psychopharmacologia. 1975 Nov 21;44(3):257-62 PMID: 1208760
  22. Drugs and human memory: effects of low doses of nitrazepam and hyoscine on retention.
    Br J Clin Pharmacol. 1979 May;7(5):479-83 PMID: 475944
  23. Studies on human memory: the interactions of diazepam, scopolamine, and physostigmine.
    Psychopharmacology (Berl). 1977 Mar 23;52(1):1-6 PMID: 403551
  24. Dose tolerance to lorazepam develop with once weekly dosing?
    Br J Clin Pharmacol. 1983 Dec;16(6):645-50 PMID: 6661348
Article Info
Journal
Psychopharmacology
Abbr.
Psychopharmacology (Berl)
ISSN
0033-3158
Published
1991-00-00
Pages
83-90
Language
English
Region
Germany
NLM ID
7608025
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]